Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Mal4g5062 | ATGATCCCCTTAACCTTAATTGTTATCACTCTGCTTTCTGTTCTGTTTTCCTCTGTTTTTGCTTCATCCTTGCTAAGTGATTTCCATGCTCTAGTCACACTTAGAGAAGGATTTCAATTCACAAACCCAGTTGTAAATACATGGAACACTTCCAATTTCAACTCAGTTTGTTCGTGGGCTGGAATTCAATGCCACCAGGGTCGAGTCGTGTCCGTAGACTTAACAGATTTGAATCTGTTTGGCTCTGTTTCACCTTCAATTTCATCACTTGATAAACTCACACACCTTTCCCTTGCAGGAAACAACTTCACTGGCATCATTCACATCACAAACTTAACCAACCTTCAGTTTCTAAACATTTCCAATAACCAGTTCAGTGGTCACATGAATTGGAACTACTCCACCATGGAAAACTTACAAGTTCTTGATGTCTACAACAATAACTTCACTTCCTTGCTTCCATTGGGTCTTCTTAGTTTGAAGAAAAACCTCAAACACTTGGATCTAGGTGGTAACTTTTTCTTTGGTGAAATCCCAAAAAGCTATGGAAAATTTGTTTCTCTTGAGTATCTTTCACTAGCTGGAAATGATATTAGTGGAAAAATCCCTGGTGAGTTGGGGAATTTAAGTAACTTGAGAGAGATTTACTTGGGCTATTACAATTCTTATGAAGGTGGAATTCCAGCGGAATTTGGAAAGTTAACAAATTTGGTTCACATGGATCTTTCAAGCTGTGATTTGGATGGTTCAATACCAAAAGAGTTAGGTAACTTGAAAGAGCTAAACACACTTTACTTGCATATAAACCAGCTTTCAGGTTCAATACCAAAACACCTTGGTAACTTAACAAACTTGCTCTACCTTGACCTTTCAAGCAATGCACTCACAGGTGAAATTCCAATTGAGTTCATCAACCTCAACCGCCTCACGCTTCTCAATCTTTTCTTGAACAGGTTACATGGTTCTATACCTGACTACATTGCAGATTTTCCTGATTTAGACACACTTGGCCTTTGGATGAACAACTTCACTGGTGAAATTCCATACAAACTTGGTCTTAATGGAAAGCTTCAACTACTTGACTTGTCCTCTAATAAGCTCACTGGTGTCATTCCACCTCATCTTTGTTCCTCAAATCAGCTTAAAATTTTGATTCTTCTCAATAATTTTCTCTTTGGACCTATACCTGAAGGTTTGGGAACATGTTACACTCTCATTAGAGTGAGATTAGGAGAGAATTACTTAAATGGTAGCATTCCAAATGGTTTTCTTTACCTTCCTAAGCTAAATTTAGCAGAGTTGAAAAACAATTACTTGTCAGGAACATTGTCTGAAAATGGTAATATTTCTTCTAAGCCTGTTAGTTTAGAACAACTTGATTTGTCAAACAATGCATTGTCTGGTCCTTTACCACACTCACTCTCAAATTTCACTTCCCTACAAATCCTTTTGCTTAGTGGAAACCAATTCTCAGGTCCAATTCCACCTTCCATTGGAGGACTAGATCAAGTGCTGAAACTCGACATTAGCACAAACTCATTATCCGGTGAAATTCCGCCCGAAATTGGTTACTGTGTTCATCTTACCTACCTTGACATGAGCCAGAACAATCTCTCAGGCTCTATTCCACCATTGATTTCCAACATCCGTATTTTGAATTACTTGAACTTGTCTAGAAATCATTTGAACCAAACCATTCCAAGATCAATAGGAACAATGAAAAGTCTCACAGTTGCTGATTTCTCCTTCAACGAATTCTCCGGTAAATTGCCAGAATCAGGTCAATTTTCATTCTTTAACGCCTCGTCATTCGCAGGAAATCCTAAACTATGTGGTTCTCTATTGAACAATCCATGTAAATTGACAAGAGTGAAATCTACATCAGGAAAAAATAATTCAGATTTCAAGCTGATATTCGCGCTTGGCCTATTGATATGTTCATTAGTATTTGCTGTTGCAGCCATTGTAAAGGCTAAGTCATTCAAAAAAAGTGGCCCTGGTTCTTGGAAGATGACTGCTTTTCAAAAGCTCGAATTCACAGTTTCCGATATCCTTGAATGCGTGAAAGATGGGAATGTTATTGGAAGAGGAGGTGCAGGGATAGTTTACCATGGAAAAATGCCAAATGGGGTGGAAATAGCAGTGAAGAAGCTACTTGGGTTTGGTGCAAATAGCCATGATCATGGTTTTAGAGCTGAAATTCAAACACTTGGAAACATAAGGCATAGAAACATAGTGAGGCTACTTGCATTTTGTTCAAACAAAGAAACAAATCTTCTTGTGTATGAATACATGAGAAATGGGAGCTTAGGTGAGACATTGCATGGGAAAAAAGGTGCGTTCTTGAGCTGGAACTTTAGGTACAAAATTTCTATTGATTCGGCGAAAGGACTCTGCTACCTTCACCATGATTGTTCTCCTTTGATCCTCCATAGAGACGTGAAATCCAATAACATTTTGTTGAGTTCAAATTTCGAAGCACATGTGGCTGATTTCGGGCTGGCAAAGTTCTTGGTCGATGGTGCTGCATCAGAGTGCATGTCCTCAATTGCAGGCTCCTATGGCTACATTGCACCAGAATATGCTTATACATTGAGGGTAGATGAAAAGAGTGATGTTTATAGTTTTGGAGTTGTTCTATTAGAGCTTCTAACAGGGAGGAAACCAGTGGGAGATTTTGGAGAAGGCGTGGATCTTGTACAATGGTGCAAGAAAGCAACAAATGGACGAAGAGAAGAGGTTGTCAACATAATTGATTCAAGACTCATGGTGGTGCCAAAAGAAGAAGCCATGCACATGTTCTTCATTGCAATGTTATGCTTAGAAGAGAACAGTGTACAAAGACCAACCATGAGGGAAGTTGTTCAGATGCTTTCTGAATTTCCAAGACAATCATCTGATCAACAATCTTCTTCTTCTCATCCACCAAACAAAAACTTAATTCAAAATCATAAATTACCTTGTCCTCCTACTTTTAAACAAGACCTTTTGGTTTAA | 2997 | 0.3854 | MIPLTLIVITLLSVLFSSVFASSLLSDFHALVTLREGFQFTNPVVNTWNTSNFNSVCSWAGIQCHQGRVVSVDLTDLNLFGSVSPSISSLDKLTHLSLAGNNFTGIIHITNLTNLQFLNISNNQFSGHMNWNYSTMENLQVLDVYNNNFTSLLPLGLLSLKKNLKHLDLGGNFFFGEIPKSYGKFVSLEYLSLAGNDISGKIPGELGNLSNLREIYLGYYNSYEGGIPAEFGKLTNLVHMDLSSCDLDGSIPKELGNLKELNTLYLHINQLSGSIPKHLGNLTNLLYLDLSSNALTGEIPIEFINLNRLTLLNLFLNRLHGSIPDYIADFPDLDTLGLWMNNFTGEIPYKLGLNGKLQLLDLSSNKLTGVIPPHLCSSNQLKILILLNNFLFGPIPEGLGTCYTLIRVRLGENYLNGSIPNGFLYLPKLNLAELKNNYLSGTLSENGNISSKPVSLEQLDLSNNALSGPLPHSLSNFTSLQILLLSGNQFSGPIPPSIGGLDQVLKLDISTNSLSGEIPPEIGYCVHLTYLDMSQNNLSGSIPPLISNIRILNYLNLSRNHLNQTIPRSIGTMKSLTVADFSFNEFSGKLPESGQFSFFNASSFAGNPKLCGSLLNNPCKLTRVKSTSGKNNSDFKLIFALGLLICSLVFAVAAIVKAKSFKKSGPGSWKMTAFQKLEFTVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGANSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGETLHGKKGAFLSWNFRYKISIDSAKGLCYLHHDCSPLILHRDVKSNNILLSSNFEAHVADFGLAKFLVDGAASECMSSIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRKPVGDFGEGVDLVQWCKKATNGRREEVVNIIDSRLMVVPKEEAMHMFFIAMLCLEENSVQRPTMREVVQMLSEFPRQSSDQQSSSSHPPNKNLIQNHKLPCPPTFKQDLLV* | 999 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Mal4g5062 | 998 | Gene3D | Ribonuclease Inhibitor | 221 | 331 | IPR032675 | - | |
Mal4g5062 | 998 | Pfam | Leucine Rich Repeat | 163 | 181 | IPR001611 | GO:0005515 | |
Mal4g5062 | 998 | Pfam | Leucine Rich Repeat | 356 | 376 | IPR001611 | GO:0005515 | |
Mal4g5062 | 998 | Pfam | Leucine rich repeat N-terminal domain | 26 | 64 | IPR013210 | - | |
Mal4g5062 | 998 | SUPERFAMILY | RNI-like | 71 | 392 | - | - | |
Mal4g5062 | 998 | SMART | LRR_typ_2 | 549 | 573 | IPR003591 | - | |
Mal4g5062 | 998 | SMART | LRR_typ_2 | 136 | 159 | IPR003591 | - | |
Mal4g5062 | 998 | SMART | LRR_typ_2 | 90 | 112 | IPR003591 | - | |
Mal4g5062 | 998 | SMART | LRR_typ_2 | 282 | 306 | IPR003591 | - | |
Mal4g5062 | 998 | SMART | LRR_typ_2 | 234 | 258 | IPR003591 | - | |
Mal4g5062 | 998 | SMART | LRR_typ_2 | 185 | 209 | IPR003591 | - | |
Mal4g5062 | 998 | SMART | LRR_typ_2 | 477 | 501 | IPR003591 | - | |
Mal4g5062 | 998 | SMART | LRR_typ_2 | 355 | 378 | IPR003591 | - | |
Mal4g5062 | 998 | MobiDBLite | consensus disorder prediction | 961 | 990 | - | - | |
Mal4g5062 | 998 | PANTHER | UNNAMED PRODUCT | 5 | 967 | - | - | |
Mal4g5062 | 998 | MobiDBLite | consensus disorder prediction | 961 | 980 | - | - | |
Mal4g5062 | 998 | Gene3D | Phosphorylase Kinase; domain 1 | 653 | 764 | - | - | |
Mal4g5062 | 998 | ProSiteProfiles | Protein kinase domain profile. | 688 | 962 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Mal4g5062 | 998 | Gene3D | Transferase(Phosphotransferase) domain 1 | 765 | 984 | - | - | |
Mal4g5062 | 998 | PANTHER | LEUCINE-RICH REPEAT RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE BAM3 | 5 | 967 | - | - | |
Mal4g5062 | 998 | SUPERFAMILY | Protein kinase-like (PK-like) | 677 | 958 | IPR011009 | - | |
Mal4g5062 | 998 | ProSiteProfiles | Leucine-rich repeat profile. | 92 | 113 | IPR001611 | GO:0005515 | |
Mal4g5062 | 998 | SUPERFAMILY | L domain-like | 355 | 612 | - | - | |
Mal4g5062 | 998 | Gene3D | Ribonuclease Inhibitor | 136 | 220 | IPR032675 | - | |
Mal4g5062 | 998 | Gene3D | Ribonuclease Inhibitor | 332 | 622 | IPR032675 | - | |
Mal4g5062 | 998 | ProSiteProfiles | Leucine-rich repeat profile. | 527 | 549 | IPR001611 | GO:0005515 | |
Mal4g5062 | 998 | Gene3D | Ribonuclease Inhibitor | 26 | 135 | IPR032675 | - | |
Mal4g5062 | 998 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 809 | 821 | IPR008271 | GO:0004672|GO:0006468 | |
Mal4g5062 | 998 | ProSiteProfiles | Leucine-rich repeat profile. | 138 | 159 | IPR001611 | GO:0005515 | |
Mal4g5062 | 998 | SMART | serkin_6 | 688 | 962 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Mal4g5062 | 998 | Pfam | Protein tyrosine and serine/threonine kinase | 691 | 958 | IPR001245 | GO:0004672|GO:0006468 |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Mal4g5062 | Mal-Chr4 | 130737539 | 130742104 | Dispersed/Transposed |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Mal4g5062 | 21 | 975 | Receptor kinase-like Gene Family | AT5G65700 | 57.143 | 0.0 | 1080 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XI-1 | Mal4g5062 | PK_Tyr_Ser-Thr | 2.2e-44 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Mal4g5062 | - | - | qsu:112009585 | 1504.58 |